PRICE T ROWE ASSOCIATES INC /MD/
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,665,795
+$418,270 QoQ
Shares Held
148,347
+43.6% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. SRPT ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,665,795 | 148,347 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,247,525 | 103,287 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,937,617 | 90,038 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,734,819 | 90,027 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,313,005 | 76,784 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,204,986 | 238,248 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $29,383,803 | 241,663 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,540,606 | 236,533 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,724,740 | 340,030 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $65,373,157 | 504,968 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $71,332,741 | 739,736 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $95,516,025 | 787,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $89,431,072 | 780,921 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $161,459,850 | 1,171,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $108,418,678 | 836,693 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $134,733,999 | 1,218,871 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $87,241,971 | 1,163,847 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $88,807,206 | 1,136,805 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,236,997 | 735,558 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $65,609,381 | 709,444 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $56,065,466 | 721,192 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $52,480,523 | 704,153 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,088,968 | 1,302,651 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $188,324,072 | 1,341,053 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $251,152,246 | 1,566,373 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $165,002,678 | 1,686,799 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||